Articles

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

Moffitt Cancer Center, Tampa, FL
Cornell University/New York Presbyterian Hospital, New York, NY
Indiana University Cancer Center, Indianapolis, IN
Sunesis Pharmaceuticals, Inc., South San Francisco, CA
Sunesis Pharmaceuticals, Inc., South San Francisco, CA
PharmaPacific, Inc., Woodside, CA
Sunesis Pharmaceuticals, Inc., South San Francisco, CA
Sunesis Pharmaceuticals, Inc., South San Francisco, CA
Sunesis Pharmaceuticals, Inc., South San Francisco, CA
MD Anderson Cancer Center, Houston, TX
Rocky Mountain Blood and Marrow Transplant Center, Denver, CO
Medical University of South Carolina, Charleston, SC
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Vol. 100 No. 2 (2015): February, 2015 https://doi.org/10.3324/haematol.2014.114769